Generation an induced pluripotent stem cell line SXMUi001-A derived from a hemophilia B patient carries variant F9 c.223C>T(p.R75X)

被引：3
|
作者：
Ma, Yanchun [1 ]
Sun, Wenwen [1 ]
Liu, Xiue [1 ]
Ren, Juan [1 ]
Zhang, Xialin [2 ]
Zhang, Ruijuan [2 ]
Zhao, Lidong [1 ]
Yang, Linhua [1 ]
Wang, Gang [1 ]
机构：
[1] Shanxi Med Univ, Dept Hematol, Hosp 2, Taiyuan 030001, Shanxi, Peoples R China
[2] Shanxi Med Univ, Shanxi Bethune Hosp, Tongji Shanxi Hosp, Shanxi Acad Med Sci,Hosp 3,Dept Hematol, Taiyuan 030032, Shanxi, Peoples R China
来源：
STEM CELL RESEARCH | 2022年 / 60卷
关键词：
D O I：
10.1016/j.scr.2022.102684
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
Hemophilia B (HB) is an X chromosome-linked recessive disorder caused by a quantitative or qualitative defect of coagulation zymogen factor IX. In this study, urine cells were collected from a patient with HB who carries variant F9 c.223C > T (p.R75X), and reprogrammed into induced pluripotent stem cells (iPSCs) using the reprogramming factors, OCT4, SOX2, m-MYC, and KLF4. The HB-iPSC line (SXMUi001-A) has characteristics similar to human embryonic stem cell, namely, pluripotency and the potential to differentiate into three germ layers. This cell line can be used as a disease model for exploring the molecular mechanism and readthrough treatment of HB.
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Generation of an induced pluripotent stem cell line from a patient with global development delay carrying DYRK1A mutation (c.1730T>A) and a gene correction isogenic iPSC line
    Ma, Ling
    Wu, Ziyan
    Tang, Qingyuan
    Ji, Xiaoli
    Mei, Yuting
    Peng, Ting
    Xu, Qiong
    Zhou, Wenhao
    Xiong, Man
    STEM CELL RESEARCH, 2021, 53
  • [32] Generation of induced pluripotent stem cells, KCi004-A derived from a male with Parkinson's disease and homozygous for the PINK1 variant c.1366C > T, p.Gln456
    Larsen, Lasse Jonsgaard
    Moller, Lisbeth Birk
    STEM CELL RESEARCH, 2023, 71
  • [33] Establishment of an induced pluripotent stem cell line from a Noonan syndrome patient with the heterozygote mutation p.S257L (c.770C > T) in RAF1 gene
    Guo, Xiaoling
    Qian, Rengcheng
    Yang, Liang
    Chen, Huihui
    Ding, Yinjuan
    Shan, Xiaoou
    Chen, Congde
    Ni, Wenfei
    Lin, Jian
    Chu, Maoping
    STEM CELL RESEARCH, 2021, 53
  • [34] Generation of a human induced pluripotent stem cell line FMUPDCi001-A from a patient with mental retardation, autosomal recessive 36 (MRT36) carrying the variants c.219dupA and c.587C > T in ADAT3
    Hu, Xiaoyu
    Xiong, Shiyi
    Zhou, Xinyao
    Sun, Luming
    STEM CELL RESEARCH, 2022, 61
  • [35] Generation of an induced pluripotent stem cell line (PUMCHi006-A) derived from a patient with pulmonary arterial hypertension carrying heterozygous c.1339 G > A mutation in PTGIS gene
    Zhu, Yong-Jian
    Zhang, Si-Jin
    Wu, Xiao-Han
    Lian, Tian-Yu
    He, Yang-Zhige
    Zhang, Ze-Jian
    Lu, Dan
    Sun, Kai
    Wang, Hui-Fang
    Jing, Zhi-Cheng
    STEM CELL RESEARCH, 2020, 49
  • [36] Generation of an induced pluripotent stem cell line (SHCDNRi001-A) from a patient with X -linked Alport syndrome carrying a heterozygous p.G409S (c. 1225 G > A) mutation in the COL4A5 gene
    Sun, Lei
    Zhang, Jing
    Kuang, Xin-yu
    Kang, Yu-lin
    Wu, Ying
    Huang, Wen-yan
    STEM CELL RESEARCH, 2020, 45
  • [37] Generation of an induced pluripotent stem cell line XJHi001-A from a fibronectin glomerulopathy patient carrying a heterozygous NM_212482.2 (C.5888-1G> C) mutation in the FN1 gene
    She, Lecheng
    Li, Xiayin
    Bai, Ming
    STEM CELL RESEARCH, 2023, 72
  • [38] An induced pluripotent stem cell line (TRNDi010-C) from a patient carrying a homozygous p.R401X mutation in the NGLY1 gene
    Yang, Shu
    Cheng, Yu-Shan
    Li, Rong
    Pradhan, Manisha
    Hong, Junjie
    Beers, Jeanette
    Zou, Jizhong
    Liu, Chengyu
    Might, Matt
    Rodems, Steven
    Zheng, Wei
    STEM CELL RESEARCH, 2019, 39
  • [39] Generation of an induced pluripotent stem cell line (FDCHI007-A) derived from a patient with developmental and epileptic encephalopathy Type 31 carrying heterozygous c.545C > A mutation in DNM1 gene
    Xu, Yan
    Wang, Xinhua
    Qiu, Tian
    Wang, Ji
    Wang, Yi
    Wu, Bingbing
    Zhou, Yuanfeng
    STEM CELL RESEARCH, 2022, 60
  • [40] Human induced pluripotent stem cell line YCMi007-A generated from a dilated cardiomyopathy patient with a heterozygous dominant c.613C > T (p. Arg205Trp) variant of the TNNT2 gene
    Jeon, Sae-Bom
    Kim, Hyoeun
    Chun, Kyeong-Hyeon
    Oh, Jaewon
    Kwon, Chulan
    Choi, Hyo-Kyoung
    Kim, Sangwoo
    Kim, Hyoung-Pyo
    Kim, In-Cheol
    Yoo, Jung-Yoon
    Park, Sahng Wook
    Kang, Seok-Min
    Lee, Seung-Hyun
    STEM CELL RESEARCH, 2023, 67
12345